心脏骤停研究中合并症与病情严重程度评分及指数的调整频率
该研究系统检索2015年报告心脏骤停生存结局的文献,统计使用病情严重程度和合并症评分/指数的研究比例,并测量调整后效应估计值的变化幅度。213项研究中仅60项(28%)使用了此类评分或指数,其中39项(65%)用风险评分和指数来校正合并症或病情严重程度的混杂效应。当模型纳入病情严重程度或合并症调整时,效应量向无效方向变化的中位幅度为14%(四分位距-37.7至4.4)。作者认为,病情严重程度和合并症混杂是非随机心脏骤停研究中的重要偏倚来源。
要点
- 213项报告心脏骤停生存结局的研究中,仅60项(28%)使用了病情严重程度或合并症评分/指数。
- 使用评分/指数的60项研究中,39项(65%)用风险评分和指数校正合并症或病情严重程度的混杂效应。
- 模型纳入病情严重程度或合并症调整后,效应量向无效方向变化的中位幅度为14%(四分位距-37.7至4.4)。
- 作者认为,病情严重程度和合并症混杂是非随机心脏骤停研究中的重要偏倚来源。
- 观察性心脏骤停研究若未调整病情严重程度和合并症,其结果解读需谨慎。
适用人群与场景
- 2015年发表的、报告心脏骤停生存结局的心脏骤停研究。
研究设计与关键结果
- 研究类型为系统检索,检索2015年报告心脏骤停生存结局且使用病情严重程度和合并症指数及评分的研究。
- 213项报告生存结局的心脏骤停研究中,60项(28%)使用了病情严重程度或合并症指数及评分。
- 使用评分/指数的60项研究中,39项(65%)用风险评分和指数校正合并症或病情严重程度的混杂效应。
- 模型纳入病情严重程度或合并症调整后,效应量向无效方向变化的中位幅度为14%(四分位距-37.7至4.4)。
证据类型、等级与局限
- 证据类型:系统检索(系统评价)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,病情严重程度和合并症混杂是非随机心脏骤停研究中的重要偏倚来源。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Previous research demonstrates that results from observational research correlate well with results from clinical trials, and if the former are well designed these can guide clinical practice. Observational studies in cardiac arrest research are beset by confounding due to illness severity and comorbidity. We aimed to count the number of studies that utilize comorbidity and illness severity scores and indices, and to measure the change in results across analyses that adjust for scores and indices.
METHODS: A systematic search of databases for cardiac arrest studies that report survival outcomes for 2015 and that utilize illness severity and comorbidity indices and scores was conducted. We quantified the proportion of studies and the change in magnitude of estimates when adjustment for indices and scores were used.
RESULTS: Sixty (28%) of 213 cardiac arrest studies that report survival outcomes utilize illness severity or comorbidity indices and scores, of which 39 studies (65%) used risk scores and indices to account for the confounding effect of comorbidity or illness severity. A 14% change towards the null in the magnitude of effect sizes was apparent when models included illness severity or comorbidity adjustment (interquartile range -37.7 to 4.4).
CONCLUSIONS: A small proportion of cardiac arrest studies account for illness severity and comorbidity with scores and indices, and such adjustment tend to drive estimates towards the null (no difference in groups being compared). Confounding by illness severity and comorbidity is a significant source of bias in non-randomized cardiac arrest studies.
参考来源
- Fouche PF, Carlson JN, Ghosh A, et al. Frequency of adjustment with comorbidity and illness severity scores and indices in cardiac arrest research. Resuscitation. 2016. PMID: 27837648. doi:10.1016/j.resuscitation.2016.10.020
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。